ITGB8 and colorectal carcinoma: Knocking down ITGB8 in CRC cells reduced mesenchymal marker expression (e.g., N-cadherin and vimentin) at both mRNA and protein levels, effectively reversing the migratory and colonization advantages conferred by AKR1B10 abrogation (Fig. 3, I to K, and fig.